Delivery Order SPE2DR25D2006-SPE2DR26F56AN
- Not listed
- The Defense Logistics Agency awarded a $4,927.87 delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Kerendia 10 mg tablets (90-count packages). This contract, issued under a firm fixed-price arrangement with no set-aside designation, reflects a competitive award to support federal medical procurement needs. The delivery order is scheduled for completion by October 30, 2025, with performance to be executed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count) on October 27, 2025, with a ceiling value of $1,466.44 and an ultimate completion date of October 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction under AmerisourceBergen's existing pharmaceutical supply contract with DLA. The place of performance is located in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Kerendia 10 mg tablets (30-count units) valued at $2,456.94. This firm fixed-price delivery order, with an ultimate completion date of October 29, 2025, represents a non-set-aside, competitively awarded contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $4,080.81 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count package). This firm fixed price, non-set-aside delivery order was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,210.89 delivery order to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count supply) on October 27, 2025, with an ultimate completion date of October 28, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child award, this delivery order falls under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $2,212.34 to AmerisourceBergen Drug Corp for Kerendia 20 mg tablets (30-count units) under a firm fixed price contract type. The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-competitive delivery order fulfilled by the prime contractor's Conshohocken, Pennsylvania facility. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a $47,741.59 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Kerendia 10 mg tablets (30-count packages). The delivery order, which is unclassified as a set-aside contract, is scheduled for completion by September 4, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract issued under AmerisourceBergen Drug Corp's broader...
- The Defense Logistics Agency awarded a delivery order valued at $2,737.75 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (90-count supply) on September 12, 2025, with completion scheduled for September 15, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,899.19 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (90-count supply) on November 12, 2025, with an ultimate completion date of November 13, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a competitive procurement of pharmaceutical products supporting federal medical supply needs....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 17, 2025, for the supply of Kerendia 20 mg tablets (30-count units) valued at $2,799.21. This firm fixed-price delivery order, with an ultimate completion date of May 19, 2025, represents a non-competitive, non-set-aside award to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The product will be delivered to the same location, supporting the federal government's...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F56ANDelivery Order
The Defense Logistics Agency awarded a $4,290.06 delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Kerendia 20 mg tablets (30-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 13, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal military and veteran healthcare procurement through the DLA Medical Supply Chain. The company maintains an extensive portfolio of pharmaceutical products and medical supplies including brand-name medications, generics, vaccines, and specialized healthcare commodities across multiple therapeutic domains. The underlying IDC vehicle enables AmerisourceBergen to provide comprehensive global pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with delivery orders structured on a firm fixed-price basis to meet ongoing medical supply requirements for military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 11/12/25 |